Clinical trials
Completed Phase 1 Leukemia, Myelomonocytic, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
99 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 3 |
| 2002 | 5 |
| 2003 | 3 |
| 2004 | 8 |
| 2005 | 5 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 99 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 19 |
| M.D. Anderson Cancer Center | 8 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 7 |
| Memorial Sloan Kettering Cancer Center | 5 |
| Celgene | 3 |
| Fred Hutchinson Cancer Center | 3 |
| Roswell Park Cancer Institute | 3 |
| Vion Pharmaceuticals | 3 |
| Case Comprehensive Cancer Center | 2 |
| Dana-Farber Cancer Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelomonocytic, Chronic | 99 |
| Leukemia, Myeloid, Acute | 84 |
| Myelodysplastic Syndromes | 63 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 58 |
| Leukemia | 45 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 43 |
| Myeloproliferative Disorders | 41 |
| Blast Crisis | 37 |
| Primary Myelofibrosis | 33 |
| Hodgkin Disease | 31 |
Trials
Showing 1 to 25 of 99. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.